Literature DB >> 1689629

Serum and pleural adenosine deaminase. Correlation with lymphocytic populations.

M F Baganha1, A Pêgo, M A Lima, E V Gaspar, A R Cordeiro.   

Abstract

This study attempts to correlate levels of ADA in tuberculous and neoplastic pleural exudates with the different immunologic cellular expressions that follow these clinical situations. Seventy-three patients with pleural effusion were studied in order to assess ADA activity (pleural and serum); in 25 of them, a study of delayed cellular immunity (pleural and sanguineous) was performed through B, CD3, CD4, and CD8 lymphocytic populations. The activity of ADA was determined, and the study of lymphocytic populations was made through the use of monoclonal antibodies. The data obtained showed the following: levels of ADA were significantly (p less than 0.0005) higher in the pleural fluid and the serum of tuberculous effusions compared to neoplastic effusions; percentages of CD3 and CD4 T-cells were significantly (p less than 0.05 and p less than 0.0005, respectively) greater in tuberculous effusions. The statistical study of the levels of ADA activity and the percentage of CD4 T-cells in pleural exudates produced a significant regression curve (r = 0.612 and p less than 0.0001) which showed a positive correlation between these two parameters. The pathogenic implications of these results suggest the possibility that ADA could be a new marker of cell-mediated immune activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689629     DOI: 10.1378/chest.97.3.605

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Lymphocyte adenosine deaminase activity in children with idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Jayant Ghosh; Ziledar Ali; Malay Sen; Rajniti Prasad
Journal:  Pediatr Nephrol       Date:  2005-08-13       Impact factor: 3.714

Review 2.  Tuberculous pleurisy and adenosine deaminase.

Authors:  G H Bothamley
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

3.  Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes.

Authors:  M Martin; J J Centelles; J Huguet; F Echevarne; D Colomer; J L Vives-Corrons; R Franco
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  The comparison of adenosine deaminase activity values with polymerase chain reaction results in patients with tuberculosis.

Authors:  O Canbolat; S Ulusdoyuran; G Ozgen; I Ceyhan; F Gümüşlü; A Akbay
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

5.  Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.

Authors:  Mustafa Calis; Filiz Ates; Cevat Yazici; Kader Kose; Mehmet Kirnap; Meltem Demir; Murat Borlu; Cem Evereklioglu
Journal:  Rheumatol Int       Date:  2005-05-03       Impact factor: 2.631

6.  Neopterin in tuberculous and neoplastic pleural fluids.

Authors:  M F Baganha; A Mota-Pinto; M A Pêgo; M A Marques; M A Rosa; A J Cordeiro
Journal:  Lung       Date:  1992       Impact factor: 2.584

7.  Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.

Authors:  S K Sharma; Amit Banga
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

8.  Immune status with empyema thoracis.

Authors:  O P Mishra; K Varshney; Z Ali; G Nath; V K Pathak; B K Das
Journal:  Indian J Pediatr       Date:  2004-04       Impact factor: 1.967

9.  Markers for differentiation of tubercular pleural effusion from non-tubercular effusion.

Authors:  Vivek Ambade; M M Arora; S P Rai; S K Nikumb; D R Basannar
Journal:  Med J Armed Forces India       Date:  2011-10-22

10.  Determination of adenosine deaminase activity in cattle naturally infected with Theileria annulata.

Authors:  Nuri Altuğ; Nazmi Yüksek; Zahid Tevfik Ağaoğlu; Ihsan Keleş
Journal:  Trop Anim Health Prod       Date:  2007-12-15       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.